The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126781271 12678127 1 I 20101211 20111011 20160823 20160823 EXP JP-SA-THYM-1002836 AVENTIS 0.00 A F Y 50.00000 KG 20160823 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126781271 12678127 1 SS THYMOGLOBULIN LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN 1 Intravenous (not otherwise specified) 60 MG, QD 120 MG U UNKNOWN 0 60 MG POWDER FOR SOLUTION FOR INFUSION QD
126781271 12678127 2 PS FLUDARA FLUDARABINE PHOSPHATE 1 Unknown 50 MG, QD, 5 TIMES 300 MG U UNKNOWN 20038 50 MG POWDER FOR SOLUTION FOR INFUSION QD
126781271 12678127 3 C SULFAMETHOPRIM SULFAMETHOXAZOLE 1 Unknown UNK 0
126781271 12678127 4 C SULFAMETHOPRIM SULFAMETHOXAZOLE 1 Unknown UNK 0
126781271 12678127 5 C LEVOFLOXACIN. LEVOFLOXACIN 1 Unknown UNK 0
126781271 12678127 6 C ITRACONAZOLE. ITRACONAZOLE 1 Unknown UNK 0
126781271 12678127 7 C BUSULFAN. BUSULFAN 1 Unknown UNK U 0
126781271 12678127 8 C ACICLOVIR ACYCLOVIR 1 Unknown UNK 0
126781271 12678127 9 C TACROLIMUS. TACROLIMUS 1 Unknown UNK 0
126781271 12678127 10 C METHOTREXATE. METHOTREXATE 1 Unknown UNK 0
126781271 12678127 11 C LANSOPRAZOLE. LANSOPRAZOLE 1 Unknown UNK 0
126781271 12678127 12 C RED BLOOD CELLS, CONCENTRATED HUMAN RED BLOOD CELL 1 Unknown UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126781271 12678127 1 Bone marrow conditioning regimen
126781271 12678127 2 Acute myeloid leukaemia
126781271 12678127 3 Antifungal prophylaxis
126781271 12678127 4 Antifungal prophylaxis
126781271 12678127 5 Antibiotic prophylaxis
126781271 12678127 6 Antifungal prophylaxis
126781271 12678127 7 Acute myeloid leukaemia
126781271 12678127 8 Antiviral prophylaxis
126781271 12678127 9 Prophylaxis against graft versus host disease
126781271 12678127 10 Prophylaxis against graft versus host disease
126781271 12678127 11 Prophylaxis against gastrointestinal ulcer
126781271 12678127 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126781271 12678127 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126781271 12678127 Acute graft versus host disease
126781271 12678127 Bronchopulmonary aspergillosis
126781271 12678127 Febrile neutropenia
126781271 12678127 Neutropenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126781271 12678127 1 20101211 20101212 0
126781271 12678127 2 20101207 20101212 0
126781271 12678127 3 20101126 20101212 0
126781271 12678127 4 20110126 0
126781271 12678127 5 20101119 20101227 0
126781271 12678127 6 20101204 20101223 0
126781271 12678127 7 20101207 20101210 0
126781271 12678127 8 20101207 20101227 0
126781271 12678127 9 20101213 20101220 0
126781271 12678127 10 20101215 20101220 0
126781271 12678127 11 20101119 0
126781271 12678127 12 20101208 20110214 0